Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 4
297
Views
7
CrossRef citations to date
0
Altmetric
Short Communications

Neuroprotective effects of Rosmarinus officinalis L. extract in oxygen glucose deprivation (OGD)-injured human neural-like cells

, , , , , , , & show all
Pages 669-675 | Received 23 Jan 2019, Accepted 22 Feb 2019, Published online: 02 Apr 2019

References

  • Abdelhalim A, Karim N, Chebib M, Aburjai T, Khan I, Johnston GAR, Hanrahan JR. 2015. Antidepressant, anxiolytic and antinociceptive activities of constituents from Rosmarinus officinalis. J Pharm Pharm Sci. 18(4):448–459.
  • Al-Sereiti MR, Abu-Amer KM, Sen P. 1999. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol. 37(2):124–130.
  • Begum A, Sandhya S, Shaffath Ali S, Vinod KR, Reddy S, Banji D. 2013. An in-depth review on the medicinal flora Rosmarinus officinalis (Lamiaceae). Acta Sci Pol Technol Aliment. 12(1):61–73.
  • Belousov AB, Fontes JD, Freitas-Andrade M, Naus CC. 2017. Gap junctions and hemichannels: communicating cell death in neurodevelopment and disease. BMC Cell Biol. 18(Suppl 1):4.
  • Bennett MVL, Garre JM, Orellana JA, Bukauskas FF, Nedergaard M, Giaume C, Saez JC. 2012. Connexin and pannexin hemichannels in inflammatory responses of glia and neurons. Brain Res. 1487:3–15.
  • Burkovetskaya M, Karpuk N, Xiong J, Bosch M, Boska MD, Takeuchi H, Suzumura A, Kielian T. 2014. Evidence for aberrant astrocyte hemichannel activity in juvenile neuronal ceroid lipofuscinosis (JNCL). PLoS One. 9:e95023.
  • Cizauskaite U, Ivanauskas L, Jakstas V, Marksiene R, Jonaitiene L, Bernatoniene J. 2016. Rosmarinus officinalis L. extract and some of its active ingredients as potential emulsion stabilizers: a new approach to the formation of multiple (W/O/W) emulsion. Pharm Dev Technol. 21(6):716–724.
  • Contreras JE, Sánchez HA, Véliz LP, Bukauskas FF, Bennett MV, Sáez JC. 2004. Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res Brain Res Rev 47, 290–303.
  • Cragg GM, Newman DJ. 2013. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 1830(6):3670–3695.
  • de Almeida Goncalves G, de Sa-Nakanishi AB, Comar JF, Bracht L, Dias MI, Barros L, Peralta RM, Ferreira I, Bracht A. 2018. Water soluble compounds of Rosmarinus officinalis L. improve the oxidative and inflammatory states of rats with adjuvant-induced arthritis. Food Funct. 9:2328–2340.
  • de Oliveira JR, de Jesus D, Figueira LW, de Oliveira FE, Pacheco Soares C, Camargo SEA, Jorge AOC, de Oliveira LD. 2017. Biological activities of Rosmarinus officinalis L. (rosemary) extract as analyzed in microorganisms and cells. Exp Biol Med (Maywood). 242(6):625–634.
  • Decrock E, De Bock M, Wang N, Bultynck G, Giaume C, Naus CC, Green CR, Leybaert L. 2015. Connexin and pannexin signaling pathways, an architectural blueprint for CNS physiology and pathology? Cell Mol Life Sci. 72(15):2823–2851.
  • Dias PC, Foglio MA, Possenti A, de Carvalho JE. 2000. Antiulcerogenic activity of crude hydroalcoholic extract of Rosmarinus officinalis L. J Ethnopharmacol. 69(1):57–62.
  • Giaume C, Saez JC, Song W, Leybaert L, Naus CC. 2017. Connexins and pannexins in Alzheimer’s disease. Neurosci Lett.
  • Hassani FV, Shirani K, Hosseinzadeh H. 2016. Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review. Naunyn Schmiedebergs Arch Pharmacol. 389(9):931–949.
  • Hegazy AM, Abdel-Azeem AS, Zeidan HM, Ibrahim KS, Sayed EE. 2018. Hypolipidemic and hepatoprotective activities of rosemary and thyme in gentamicin-treated rats. Hum Exp Toxicol. 37(4):420–430.
  • Jessica Elizabeth DLT, Gassara F, Kouassi AP, Brar SK, Belkacemi K. 2017. Spice use in food: properties and benefits. Crit Rev Food Sci Nutr. 57(6):1078–1088.
  • Jiang Y, Wu N, Fu YJ, Wang W, Luo M, Zhao CJ, Zu YG, Liu XL. 2011. Chemical composition and antimicrobial activity of the essential oil of Rosemary. Environ Toxicol Pharmacol. 32(1):63–68.
  • Leithe E, Kjenseth A, Bruun J, Sirnes S, Rivedal E. 2010. Inhibition of connexin 43 gap junction channels by the endocrine disruptor ioxynil. Toxicol Appl Pharmacol. 247(1):10–17.
  • Montenegro L, Pasquinucci L, Zappalà A, Chiechio S, Turnaturi R, Parenti C. 2017. Rosemary essential oil-loaded lipid nanoparticles: in vivo topical activity from gel vehicles. Pharmaceutics. 9(4):48.
  • Naimi M, Vlavcheski F, Shamshoum H, Tsiani E. 2017. Rosemary Extract as a Potential Anti-Hyperglycemic Agent: Current Evidence and Future Perspectives. Nutrients. 9(9):968.
  • Ozarowski M, Mikolajczak PL, Bogacz A, Gryszczynska A, Kujawska M, Jodynis-Liebert J, Piasecka A, Napieczynska H, Szulc M, Kujawski R. 2013. Rosmarinus officinalis L. leaf extract improves memory impairment and affects acetylcholinesterase and butyrylcholinesterase activities in rat brain. Fitoterapia. 91:261–271.
  • Parenti R, Cicirata F, Zappala A, Catania A, La Delia F, Cicirata V, Tress O, Willecke K. 2010. Dynamic expression of Cx47 in mouse brain development and in the cuprizone model of myelin plasticity. Glia. 58(13):1594–1609.
  • Pejin B, Savic A, Sokovic M, Glamoclija J, Ciric A, Nikolic M, Radotic K, Mojovic M. 2014. Further in vitro evaluation of antiradical and antimicrobial activities of phytol. Nat Prod Res. 28(6):372–376.
  • Pejin B, Kojic V, Bogdanovic G. 2014. An insight into the cytotoxic activity of phytol at in vitro conditions. Nat Prod Res. 28(22):2053–2056.
  • Pejin B, Ciric A, Glamoclija J, Nikolic M, Sokovic M. 2015. In vitro anti-quorum sensing activity of phytol. Nat Prod Res. 29(4):374–377.
  • Ribeiro-Santos R, Carvalho-Costa D, Cavaleiro C, Costa HS, Albuquerque TG, Castilho MC, Ramos F, Melo NR, Sanches-Silva A. 2015. A novel insight on an ancient aromatic plant: the rosemary (Rosmarinus officinalis L.). Trends Food Sci Tech. 45(2):355–368.
  • Ronsisvalle S, Arico G, Cova AM, Blanco P, Amata E, Pappalardo M, Pasquinucci L, Spadaro A, Ronsisvalle N. 2016. Caspase-3 activation in human melanoma A375 cell line by a novel selective sigma-2 agonist. Pharmazie. 71(3):146–151.
  • Salemme A, Togna AR, Mastrofrancesco A, Cammisotto V, Ottaviani M, Bianco A, Venditti A. 2016. Anti-inflammatory effects and antioxidant activity of dihydroasparagusicacid in lipopolysaccharide-activated microglial cells. Brain Res Bull. 120:151–158.
  • Seyedemadi P, Rahnema M, Bigdeli MR, Oryan S, Rafati H. 2016. The neuroprotective effect of Rosemary (Rosmarinus officinalis L.) hydro-alcoholic extract on cerebral ischemic tolerance in experimental stroke. Iran J Pharm Res. 15(4):875–883.
  • Smyth JW, Zhang SS, Sanchez JM, Lamouille S, Vogan JM, Hesketh GG, Hong T, Tomaselli GF, Shaw RM. 2014. A 14-3-3 mode-1 binding motif initiates gap junction internalization during acute cardiac ischemia. Traffic 15, 684–699.
  • Sofowora A, Ogunbodede E, Onayade A. 2013. The role and place of medicinal plants in the strategies for disease prevention. Afr J Tradit Complement Altern Med. 10(5):210–229.
  • Sueishi Y, Sue M, Masamoto H. 2018. Seasonal variations of oxygen radical scavenging ability in rosemary leaf extract. Food Chem. 245:270–274.
  • Suggs A, Oyetakin-White P, Baron ED. 2014. Effect of botanicals on inflammation and skin aging: analyzing the evidence. Inflamm Allergy Drug Targets. 13(3):168–176.
  • Takaki I, Bersani-Amado LE, Vendruscolo A, Sartoretto SM, Diniz SP, Bersani-Amado CA, Cuman RKN. 2008. Anti-inflammatory and antinociceptive effects of Rosmarinus officinalis L. essential oil in experimental animal models. J Med Food. 11(4):741–746.
  • Venditti A, Bianco A. 2018. Sulfur-containing secondary metabolites as neuroprotective agents. Curr Med Chem.
  • Vicario N, Calabrese G, Zappala A, Parenti C, Forte S, Graziano ACE, Vanella L, Pellitteri R, Cardile V, Parenti R. 2017. Inhibition of Cx43 mediates protective effects on hypoxic/reoxygenated human neuroblastoma cells. J Cell Mol Med. 21(10):2563–2572.
  • Vicario N, Zappala A, Calabrese G, Gulino R, Parenti C, Gulisano M, Parenti R. 2017. Connexins in the central nervous system: physiological traits and neuroprotective targets. Front Physiol. 8:1060.
  • Yin X, Feng L, Ma D, Yin P, Wang X, Hou S, Hao Y, Zhang J, Xin M, Feng J. 2018. Roles of astrocytic connexin-43, hemichannels, and gap junctions in oxygen-glucose deprivation/reperfusion injury induced neuroinflammation and the possible regulatory mechanisms of salvianolic acid B and carbenoxolone. J Neuroinflammation. 15:97.
  • Zappalà A, Parenti R, La Delia F, Cicirata V, Cicirata F. 2010. Expression of connexin57 in mouse development and in harmaline-tremor model. Neuroscience. 171(1):1–11.
  • Zhou JZ, Jiang JX. Gap junction and hemichannel-independent actions of connexins on cell and tissue functions–an update. 2014. FEBS Lett 588: 1186–1192.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.